Early Clinical Development

Global resources to enhance your Phase I study’s speed, quality, and safety

Finding the right patient, target, dose/exposure, response, and commercial strategy are essential criteria for successful clinical development. A proactive, scalable, and fit-for-purpose delivery model is needed to tackle these hurdles and accelerate your Phase I trial. Improve your probability of success by partnering with Quintiles for access to our global drug development expertise, deep phase I experience, and extensive global network of sites.


Connecting insights and superior delivery for better outcomes.

Leverage our expertise and operational excellence to get to a better proof-of-concept during early clinical development.

Quintiles Early Clinical Development Services

Quintiles has been named the CRO Industry leader in Phase I studies for the fourth year in a row

With >25 years of experience running clinical trials, we understand the challenges in getting your Phase I study up and running, not to mention complete. You need a partner to compliment and work seamlessly with your unique protocol requirements and systems. Whatever the scale of your project, our approach can be tailored to your needs, to meet your goals. Our Phase I capabilities include various types of studies and services, including:

  • First-in-Human, First-in-Patient, & Healthy Volunteer Studies
  • Clinical Pharmacology
  • SAD/MAD combination studies
  • Drug-Drug Interaction Studies
  • Ethnic Bridging Studies
  • Food Effect Studies
  • Special Population/PK/PD Modeling and Simulation Support
  • AME/Mass Balance/Radiolabel Studies
  • Cardiac Safety, TQT, Idiosyncratic Toxicity
Early Clinical Development platformOur integrated platform is designed to streamline every aspect of your Phase I trial:

  • Study design
  • Patient recruitment
  • Scientific operations
  • Data analysis
  • Medical writing
  • Initial & ongoing quality management
  • Labs, BioA, EA, biomarkers, etc.
  • Advisory services to provide guidance across any stage of development

A Global Network of Sites for Powerful Benefits

Our extensive network of preselected and fully qualified sites across the US, EU, and Asia Pacific enables choices and access. Choices that best fit your needs. Access to experts and a wide range of patients. Additionally, our investments in relationships with sites can lead to cost and time savings. We care about your molecule. We care about your success. We care about providing research that creates a safer and healthier world. It all starts in Phase I. Contact us to learn more about our early clinical development capabilities.

Learn about our Phase I studies

The power of possibilities

From the ground up, Quintiles plays an essential role in helping biopharma companies like yours bring competitive drugs to market. We customize our services to help you find your edge.

Related services

Bioanalytical & ADME Laboratories
Model-based drug development
Fact Sheet Nov 11, 2016
Read More
Video Spotlights
Transforming Early Clinical Development
Transforming Early Clinical Development
Getting more value from Respiratory Clinical Trials
Getting more value from Respiratory Clinical Trials
Best Practices for Optimizing Dose Escalation in First in Human Studies.wmv
Best Practices for Optimizing Dose Escalation in First in Human Studies.wmv